Italy· 033129014
NICARDIPINA*30 cps 40 mg rilascio prolungato
A medicinal product containing nicardipina, registered in Italy by MYLAN SpA, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Nicardipina
- Manufacturer
- MYLAN SpA
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic033129014NICARDIPINA*30 cps 40 mg rilascio prolungatoEUR 4.56
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nicardipina in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCardene IVBaxter Healthcare Corporation
- United KingdomCardene 20mg capsulesLaboratoire X.O
- SpainFLUSEMIDE 20 mg COMPRIMIDOSLaboratorios Q Pharma S.L.
- FranceLOXEN 10 mg/10 mL, solution injectable (I.V.)LABORATOIRE XO
- BelgiumNicardipine Aguettant 10 mg/10 mlLaboratoire Aguettant
- SwitzerlandNicardipin Aguettant 10 mg/10 ml, solution injectableAguettant Suisse SA
- NetherlandsCardene IV, 1 mg/ml oplossing voor infusieLaboratoire X.O.
- NorwayNicardipine HCl hikmaHikma
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Belgium · Nicardipine Aguettant, Nicardipine Hikma
- Spain · Flusemide, Nerdipina Retard
- France · Loxen, Loxen Lp
- United Kingdom (Northern Ireland) · Nicardipine Hydrochloride Tillomed Laboratories, Nicardipine Laboratoire Aguettant
- Luxembourg · Nicardipine Aguettant, Rydene Iv
- Netherlands · Cardene Iv
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bf3be0c3-279f-41a7-a0a7-52a4b58fb6a2 GET /v1/drugs/bf3be0c3-279f-41a7-a0a7-52a4b58fb6a2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 4.56,
"source": "aifa",
"currency": "EUR",
"strength": "NICARDIPINA 40MG 30 UNITA' USO ORALE",
"substance": "Nicardipina",
"equivalence_group": "11A",
"transparency_flag": null
}See everything about nicardipina.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.